STOCK TITAN
  1. Home
  2. Sec-filings
  3. UTHR
  4. [Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity

United Therapeutics (UTHR) awards 760 RSUs in annual director grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Giltner Richard reported acquisition or exercise transactions in this Form 4 filing.

United Therapeutics Corp director Richard Giltner received an annual non-employee director award of 760 restricted stock units, each representing one share of common stock upon vesting.

The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Shareholders, anticipated on June 25, 2027. After this award he holds 760 RSUs and 21,884 common shares directly.

Positive

  • None.

Negative

  • None.
Insider Giltner Richard
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Unit F1, F2, F3, F4 760 $0.00 $0.00
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 760 shares (Direct); Common Stock — 21,884 shares (Direct)
Footnotes (4)
  1. F1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
  2. F2. Annual non-employee director award.
  3. F3. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
  4. F4. Not applicable as restricted stock units do not have an expiration date.
RSUs granted 760 restricted stock units Annual non-employee director award granted July 22, 2026
Vesting reference date June 25, 2027 Anticipated date of next Annual Meeting of Shareholders for RSU vesting
Common shares held 21,884 shares Direct United Therapeutics common stock holdings after reported transactions
RSU exercise price $0.0000 per share RSUs represent the right to receive one share of common stock at no cash cost
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting, one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Annual non-employee director award financial
"Annual non-employee director award."
Annual Meeting of Shareholders regulatory
"the date of the next Annual Meeting of Shareholders following the grant date"
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
vesting financial
"represents the right to receive, following vesting, one share of common stock"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did United Therapeutics (UTHR) director Richard Giltner receive in this Form 4 filing?
Director Richard Giltner received an annual non-employee director award of 760 restricted stock units (RSUs). Each RSU represents the right to receive one share of United Therapeutics common stock after vesting, as part of his equity-based board compensation.

When do the 760 RSUs granted to United Therapeutics (UTHR) director Richard Giltner vest?
The 760 RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Shareholders. The company identifies June 25, 2027 as the anticipated date of that next Annual Meeting for this award.

How many United Therapeutics (UTHR) common shares does Richard Giltner hold after this transaction?
After the reported award, Richard Giltner directly holds 21,884 shares of United Therapeutics common stock. He also directly holds 760 restricted stock units, each of which is tied to one share of common stock upon vesting.

What does each restricted stock unit represent in the United Therapeutics (UTHR) Form 4?
Each restricted stock unit granted to Richard Giltner represents the right to receive one share of United Therapeutics common stock following vesting. The award therefore provides potential future ownership without requiring any cash exercise price from the director.

Do the restricted stock units in the UTHR director award have an expiration date?
The filing states that restricted stock units do not have an expiration date. Instead, they are governed by their vesting conditions, after which each vested RSU is settled in one share of United Therapeutics common stock for the director.

Is the United Therapeutics (UTHR) RSU grant tied to the company’s Annual Meeting of Shareholders?
Yes. The RSUs become fully vested on the earlier of one year from grant or the next Annual Meeting of Shareholders. The company notes June 25, 2027 as the anticipated date of that next Annual Meeting for this specific award.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Giltner Richard
(Last)(First)(Middle)
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
(Street)
SILVER SPRING MARYLAND 20910
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock21,884D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit$0.00(1)07/22/2026A760(2)06/25/2027(3) (4)Common Stock760$0.00760D
Explanation of Responses:
1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
2. Annual non-employee director award.
3. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
4. Not applicable as restricted stock units do not have an expiration date.
Remarks:
/s/ John S. Hess, Jr. under Power of Attorney07/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR